BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Middleton CH, Irving W, Robertson JF, Murray A, Parsy-Kowalska CB, Macdonald IK, McElveen J, Allen J, Healey GF, Thomson BJ. Serum autoantibody measurement for the detection of hepatocellular carcinoma. PLoS One. 2014;9:e103867. [PMID: 25093332 DOI: 10.1371/journal.pone.0103867] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Okada R, Otsuka Y, Wakabayashi T, Shinoda M, Aoki T, Murakami M, Arizumi S, Yamamoto M, Aramaki O, Takayama T, Wakiyama S, Yanaga K, Amikura K, Kaneko H, Shimada H. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study. Int J Cancer 2020;147:2578-86. [PMID: 32574375 DOI: 10.1002/ijc.33165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Oshima Y, Shimada H, Yajima S, Nanami T, Matsushita K, Nomura F, Kainuma O, Takiguchi N, Soda H, Ueda T, Iizasa T, Yamamoto N, Yamamoto H, Nagata M, Yokoi S, Tagawa M, Ohtsuka S, Kuwajima A, Murakami A, Kaneko H. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. J Gastroenterol. 2016;51:30-34. [PMID: 25906289 DOI: 10.1007/s00535-015-1078-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
3 Welberry C, Macdonald I, McElveen J, Parsy-Kowalska C, Allen J, Healey G, Irving W, Murray A, Chapman C. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma. PLoS One 2020;15:e0232247. [PMID: 32374744 DOI: 10.1371/journal.pone.0232247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives. Front Immunol. 2018;9:947. [PMID: 29770138 DOI: 10.3389/fimmu.2018.00947] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 29.0] [Reference Citation Analysis]
5 Futami J, Nonomura H, Kido M, Niidoi N, Fujieda N, Hosoi A, Fujita K, Mandai K, Atago Y, Kinoshita R, Honjo T, Matsushita H, Uenaka A, Nakayama E, Kakimi K. Sensitive Multiplexed Quantitative Analysis of Autoantibodies to Cancer Antigens with Chemically S-Cationized Full-Length and Water-Soluble Denatured Proteins. Bioconjug Chem 2015;26:2076-84. [PMID: 26355635 DOI: 10.1021/acs.bioconjchem.5b00328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
6 Sexauer D, Gray E, Zaenker P. Tumour- associated autoantibodies as prognostic cancer biomarkers- a review. Autoimmunity Reviews 2022. [DOI: 10.1016/j.autrev.2022.103041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Macdonald IK, Parsy-Kowalska CB, Chapman CJ. Autoantibodies: Opportunities for Early Cancer Detection. Trends Cancer. 2017;3:198-213. [PMID: 28718432 DOI: 10.1016/j.trecan.2017.02.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
8 Chang Y, Liu B, Niu H, Wang Z, Xia S, Li H. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis. Medicine (Baltimore) 2020;99:e21887. [PMID: 32846849 DOI: 10.1097/MD.0000000000021887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wang K, Li M, Qin J, Sun G, Dai L, Wang P, Ye H, Shi J, Cheng L, Yang Q, Qiu C, Jiang D, Wang X, Zhang J. Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes. Cancers (Basel) 2020;12:E1271. [PMID: 32443439 DOI: 10.3390/cancers12051271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Negm OH, Hamed MR, Schoen RE, Whelan RL, Steele RJ, Scholefield J, Dilnot EM, Shantha Kumara HM, Robertson JF, Sewell HF. Human Blood Autoantibodies in the Detection of Colorectal Cancer. PLoS One 2016;11:e0156971. [PMID: 27383396 DOI: 10.1371/journal.pone.0156971] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
11 Li Y, Song R, Li X, Xu F. Expression and immunogenicity of NY-ESO-1 in colorectal cancer. Exp Ther Med 2017;13:3581-5. [PMID: 28588683 DOI: 10.3892/etm.2017.4405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
12 Campuzano S, Pedrero M, González-cortés A, Yáñez-sedeño P, Pingarrón JM. Electrochemical biosensors for autoantibodies in autoimmune and cancer diseases. Anal Methods 2019;11:871-87. [DOI: 10.1039/c8ay02742k] [Cited by in Crossref: 16] [Article Influence: 5.3] [Reference Citation Analysis]
13 Xing M, Wang X, Kiken RA, He L, Zhang JY. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. Int J Mol Sci 2021;22:6139. [PMID: 34200243 DOI: 10.3390/ijms22116139] [Reference Citation Analysis]
14 Shi L, Chevolot Y, Souteyrand E, Laurenceau E. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer. CBM 2017;18:105-16. [DOI: 10.3233/cbm-160117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hong Y, Huang J. Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma. World J Hepatol 2015; 7(11): 1581-1585 [PMID: 26085917 DOI: 10.4254/wjh.v7.i11.1581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
16 Uttley L, Whiteman BL, Woods HB, Harnan S, Philips ST, Cree IA; Early Cancer Detection Consortium. Building the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review. EBioMedicine 2016;10:164-73. [PMID: 27426280 DOI: 10.1016/j.ebiom.2016.07.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
17 Singh G, Agarwal AK, Prosek J, Jayadev MSK, Singh A. Can killers be saviors? Lupus 2017;26:903-8. [PMID: 28121242 DOI: 10.1177/0961203316688783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]